Can-Fite BioPharma (CANF) Other Non-Current Liabilities (2014 - 2019)
Can-Fite BioPharma (CANF) posted Other Non-Current Liabilities of $11000.0 for Q3 2019, up 37.5% quarter-over-quarter from $8000.0 in Q2 2019, and up 450.0% YoY from $2000.0 in Q3 2018.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Other Non-Current Liabilities (2014 - 2019) Analysis & Trends
Can-Fite BioPharma (CANF) has 6 years of Other Non-Current Liabilities data on file, last reported at $11000.0 in Q3 2019.
- For the quarter ending Q3 2019, Other Non-Current Liabilities rose 450.0% year-over-year to $11000.0; the trailing twelve-month figure through Sep 2019 stood at $11000.0 (up 450.0% YoY), and the FY2018 full-year result was $2000.0, down 60.0% from the prior year.
- Other Non-Current Liabilities was $11000.0 for Q3 2019 at Can-Fite BioPharma, up from $8000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $11000.0 in Q3 2019 to a low of $2000.0 in Q3 2018.
- A 5-year average of $6411.8 and a median of $7000.0 in 2015 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities tumbled 75.0% in 2018 and surged 450.0% in 2019, its largest moves.
- Can-Fite BioPharma's Other Non-Current Liabilities stood at $5000.0 in 2015, then jumped by 100.0% to $10000.0 in 2016, then tumbled by 50.0% to $5000.0 in 2017, then tumbled by 60.0% to $2000.0 in 2018, then surged by 450.0% to $11000.0 in 2019.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $11000.0 in Q3 2019, $8000.0 in Q2 2019, and $5000.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.12 Bn | 628.36 Bn | 17.26 Bn |
| 2 | AbbVie | 445.86 Bn | 439.29 Bn | 12.70 Bn |
| 3 | Merck | 362.13 Bn | 354.99 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.88 Bn | 261.19 Bn | 11.24 Bn |
| 5 | Pfizer | 156.96 Bn | 145.26 Bn | 10.94 Bn |
| 6 | Sanofi | 52.26 Bn | 44.88 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - |
| 8 | Incyte | 25.13 Bn | 20.59 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn |
| 10 | Can-Fite BioPharma | 1.80 Mn | -1.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 11,000.00 |
| Jun 30, 2019 | 8,000.00 |
| Mar 31, 2019 | 5,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 2,000.00 |
| Jun 30, 2018 | 5,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Dec 31, 2017 | 5,000.00 |
| Sep 30, 2017 | 8,000.00 |
| Jun 30, 2017 | 8,000.00 |
| Mar 31, 2017 | 10,000.00 |
| Sep 30, 2016 | 10,000.00 |
| Jun 30, 2016 | 7,000.00 |
| Mar 31, 2016 | 7,000.00 |
| Sep 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 7,000.00 |
| Mar 31, 2015 | 4,000.00 |
| Sep 30, 2014 | 9,000.00 |
| Jun 30, 2014 | 10,000.00 |